Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | -8.24% | +11.43% | -81.19% |
06-12 | Vivos Therapeutics, Inc. announced that it has received $7.5 million in funding | CI |
05-14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.19% | 7.55M | |
+75.69% | 12.57B | |
-23.76% | 7.43B | |
+13.12% | 7.04B | |
+17.81% | 5.64B | |
-18.10% | 4.84B | |
+18.27% | 4.22B | |
-23.85% | 3.84B | |
-27.79% | 2.73B | |
+2.97% | 2.11B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Earnings Flash (VVOS) VIVOS THERAPEUTICS Reports Q2 Revenue $3.4M, vs. Street Est of $4.1M